January 27, 2021
An NHS initiative to accelerate the uptake of innovative medical devices, diagnostics and digital products is due to launch in April.
A consultation into the MedTech Funding Mandate took place in December 2019, but the launch was delayed due to COVID-19.
Under the policy, NHS England and NHS Improvement will identify medical technologies which have been assessed and recommended by NICE as being...
October 14, 2020
Cue Health, a rapid diagnostics startup with a connected testing device platform, has been awarded $481 million from HHS and the Department of Defense (DoD) to expand production of a COVID-19 molecular test that received an Emergency Use Authorization back in June.
According to announcements from the government and the startup, the money will be used to deliver six million COVID-19 molecular...
August 11, 2020
Nurx, a startup known for online purchase and delivery of home health tests, birth control and other sensitive treatments for women, has tacked on another $22.5 million in Series C funding.
Closed in May, the raise included new backers Trustbridge, Comcast Ventures and Wittington Ventures, as well as prior backers Union Square Ventures and Kleiner Perkins Digital Growth Fund. This brings the...
August 5, 2020
Sight Diagnostics, an Israeli startup developing a machine-vision-based finger-prick analysis device, announced today $71 million in Series D funding. Koch Disruptive Technologies, Longliv Ventures and OurCrowd all participated in the round.
According to the company, this newest raise brings its lifetime funding to more than $124 million.
WHAT IT DOES
Founded in 2011, Sight Diagnostics offers an...
July 27, 2020
On Friday evening, the FDA reissued an emergency use authorization (EUA) for LabCorp's COVID-19 RE-PCR Test that now allows for testing among those without any symptoms of COVID-19.
The agency also expanded the indication to allow for pooled sample testing – a technique of combining multiple samples into a single test, and then following up with individual tests should the group be positive. The...
April 16, 2020
Polish telemedicine innovations company StethoMe has announced they will be rolling out their AI wireless stethoscope following recent collaborations with major telemedicine providers MaQuestionMedicale and HomeDoctor. The company is also in talks with other providers across Europe in the hope of expanding operations.
WHAT IT’S FOR
The EU-certified medical device, which records respiratory...
April 2, 2020
Editor's note: On the same day this story was published, the FDA publicized the first Emergency Use Authorization of a serology test, Cellex Inc.’s qSARS-CoV-2 IgG/IgM Rapid Test. This story has been updated to reflect that development.
On Tuesday morning, Los Angeles-based Bodysphere announced that it had received an Emergency Use Authorization (EUA) for a rapid COVID-19 serology test able to...
February 7, 2020
The first artificial intelligence-enabled cardiac ultrasound software has received De Novo marketing authorization, the FDA announced today. Developed by Caption Health, the Caption Guidance tool guides medical professionals through a heart disease diagnostic test that normally requires an ultrasound expert.
“Echocardiograms are one of the most widely-used diagnostic tools in the diagnosis and...
January 31, 2020
Health tech venture-backed investments continued strong in 2019, hitting a record and cementing health tech as the fastest growing healthcare sector, according to a report by Silicon Valley Bank (SVB).
The Healthcare Investments and Exits Report predicts that health tech investments in Europe and the US will continue to rise in 2020, driven by provider operations and alternative care companies....
Above: Screengrab of the MiRXES website.
January 30, 2020
MicroRNA (MiRNA) is a small RNA molecule that play a central part in the functioning of the human body and are promising markers for identifying the early-stage risk of diseases such as cancer. According to an article published in Clinical Epigenetics in 2018, the differential expression of circulating miRNAs exhibited promising potential for cancer screening without additional injury for...